Search
Vir Biotechnology Inc
VIRAdd to Watchlist
10.600USD
-0.320-2.93%
Close 09-18 16:00（ET）
1.79BMarket Cap
LossP/E TTM
Vir Biotechnology Inc (VIR) Stock Price Target & Forecast
Analyst Rating
Based on 10 analysts giving stock ratings to Vir Biotechnology Inc in the past month.
Buy
3 Strong Buy
7 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
20.778USD+99.02%
VIR Analyst Recommendation Trends
In the current month, VIR has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. VIR average Analyst price target in the last month is 20.778.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
3
3
3
3
3
3
3
2
7
7
7
7
7
7
7
8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
10
10
10
10
10
10
VIR Analyst Rating for Peer Comparison
Updated: Sep 18, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
8
13
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, VIR EPS is projected to reach -0.744 in FY2026Q3, following reported EPS of 0.477 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.49
-0.10
0.33
-0.74
-0.67
Actual
-0.31
-0.85
0.48
--
--
Surprise
+37.28%
-794.13%
+43.38%
--
--
FAQs
What is Vir Biotechnology Inc's expected revenue for the next quarter?
Vir Biotechnology Inc's expected revenue is 104.20K.
What is Vir Biotechnology Inc's price target?
Analysts forecast that Vir Biotechnology Inc's price target is USD 20.78, with the highest forecast at USD 30.00 and the lowest forecast at USD 15.00.
How have Vir Biotechnology IncVIR's recent earnings per share performed?
The market expectation was USD 0.48, while Vir Biotechnology IncVIR's earnings per share (EPS) for the previous quarter was USD -0.85. EPS for the next quarter is expected at USD -0.74.
What is the analyst rating for Vir Biotechnology Inc?
Based on the ratings of Vir Biotechnology Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.